First published online 19 August 2003
doi: 10.1242/jcs.00672
Interaction of the actin cytoskeleton with microtubules regulates secretory organelle movement near the plasma membrane in human endothelial cells
Jean-Baptiste Manneville1,*,
Sandrine Etienne-Manneville2,
Paul Skehel3,
Tom Carter4,
David Ogden1 and
Michael Ferenczi5
1 National Institute for Medical Research, London NW7 1AA, UK
2 MRC Laboratory for Molecular Cell Biology, UCL, London WC1E 6BT, UK
3 Department of Neuroscience, University of Edinburgh, Edinburgh EH8 9YL,
UK
4 Department of Pharmacology, UCL, London WC1E 6BT, UK
5 Department of Biomedical Sciences, Imperial College, London SW7 2AZ, UK

View larger version (31K):
[in a new window]
|
Fig. 4. Short-range motions of WPb in HUVECs. (A) Short-range diffusive motions
visualized by averaging the same sequence as in
Fig. 3A. Examples are shown of
simple diffusion (WPb 1), directed diffusion (WPb 2) and restricted diffusion
(WPb 3). The WPb x-y trajectories are given in the centre
panels (x and y in µm). Three-dimensional MSD plots
(right-hand panels) were fitted according to Eqs 1-3 (see Materials and
Methods). The parameters deduced from the fits are: WPb 1, D=1.5
10-4 µm2/second; WPb 2,
D=1.05x10-3 µm2/second,
v=1.07x10-2 µm/second; WPb 3,
D=1.0x10-4 µm2/second,
Dcage=3.6x10-5
µm2/second, Rcage=49 nm. Bar, 10
µm. (B) Averages of simple diffusion (n=21), directed diffusion
(n=11), and restricted diffusion (n=16) 3D MSD plots.
|
|

View larger version (80K):
[in a new window]
|
Fig. 1. Visualization of secretory organelles in living HUVECs by TIRF microscopy.
(A,B) Epifluorescence (EPI) and corresponding TIRF (TIRF) images of tPAGFP 4
hours after microinjection (A) and Rab27a-GFP 48 hours after microinjection
(B). Details of the TIRF image show small diameter tPA-GFP vesicles (A) and
tubular rod-shaped Rab27a-GFP organelles (B). Arrowheads indicate the Golgi
region in epifluorescence images. (C) Rab27a-GFP colocalizes with vWF on
Weibel-Palade bodies (TIRF images; green, Rab27a-GFP; red, vWF). Bars, 10
µm.
|
|

View larger version (54K):
[in a new window]
|
Fig. 2. Exocytosis of endothelial secretory organelles. (A,B) Individual fusion
events of a Rab27a-GFP-positive organelle (A) and a tPA-GFP vesicle (B)
stimulated by 100 µM histamine. Rab27a-GFP diffuses in the plasma membrane,
whereas tPA-GFP remains at the fusion site after exocytosis. Numbers indicate
time (in seconds) relative to the moment of fusion. Lower panels show
three-dimensional luminance plots of four successive frames starting one frame
before fusion. Bars, 1 µm. (C) Plot of the half-width
Rfluo2(t) obtained by a
Gaussian fit of the distribution of fluorescence intensities from the images
shown in A. A linear fit (grey line) yields the diffusion coefficient of
Rab27a-GFP in the membrane Dfluo=0.12±0.01
µm2/second. (D) Time course of the fluorescence intensity of the
tPA-GFP vesicle shown in B. The characteristic decay time of the fluorescence
is given by an exponential fit (grey line): =13.7±0.9 s.
|
|

View larger version (25K):
[in a new window]
|
Fig. 6. Effects of cytoskeleton disruption on long-range movements of WPb. (A)
Trajectories of the ten most mobile WPb in a nontreated cell (NT), a
nocodazole-treated cell (noco) and a latrunculin B-treated cell (latB). Bars,
10 µm. (B) Analysis of long-range motions in nontreated cells (NT,
n=54 from three cells), nocodazole-treated cells (noco, n=2
from three cells), cells treated with the kinesin ATPase inhibitor ATA
(n=16 from three cells), latrunculin B-treated cells (n=33
from three cells) and cells treated with the myosin ATPase inhibitor BDM
(n=44 from three cells). Parameters derived from three-dimensional
tracking are: frequency of long-range motions (in s-1), defined as
the number of WPb undergoing long-range motions per total number of WPb per
unit time, average and maximum velocities (in µm/second) and total run
length (in µm).
|
|

View larger version (28K):
[in a new window]
|
Fig. 7. Effects of cytoskeleton disruption on short-range motions of WPb. (A) Data
from all classes of short-range diffusive behaviours (simple, directed and
restricted diffusion) were pooled to calculate the average diffusion
coefficient D (left panel) and to plot the averaged three-dimensional
MSD (right panel) in nontreated cells (circles or NT, n=48 from three
cells), nocodazole-treated cells (diamonds or noco, n=51 from three
cells), cells treated with the kinesin inhibitor ATA (n=48 from three
cells), latrunculin B-treated cells (triangles or latB, n=60 from
three cells) and cells treated with the myosin inhibitor BDM (n=59
from three cells). A numerical constant was added to the averaged MSD data so
that all three plots coincide on their first data point. (B) Same analysis as
in A for vertical motions (in the z direction) in nontreated cells
(n=47 from three cells), nocodazole-treated cells (n=46 from
three cells), cells treated with the kinesin inhibitor ATA (n=41 from
three cells), latrunculin B-treated cells (n=53 from three cells) and
cells treated with the myosin inhibitor BDM (n=53 from three cells).
The left-hand panel shows the z-direction diffusion coefficient
Dz. Averaged one-dimensional
MSDz are plotted on the right panel. A numerical constant
was added to the averaged MSD data so that all three plots coincide on their
first data point.
|
|

View larger version (48K):
[in a new window]
|
Fig. 8. Effects of cytoskeleton disruption on simple, directed and restricted
diffusive behaviours of WPb. A percentage of simple (S), directed (D) and
restricted (R) diffusion in nontreated cells (NT), nocodazole-treated cells
(noco) and latrunculin-treated cells (latB). (B) Restricted diffusion.
Diffusion coefficient of the cage (Dcage in
µm2/second) and radius of the cage
(Rcage in µm) in nontreated cells
(n=16), nocodazole-treated cells (n=1) and
latrunculin-treated cells (n=11).
|
|
© The Company of Biologists Ltd 2003